PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | |cirrhosis |
| Sentences | 175 |
| PubMedID- 26045708 | Alcoholic liver disease can lead to cirrhosis and there is underlying cirrhosis in many ah cases (2, 9). |
| PubMedID- 23543867 | Additional subgroup analysis to estimate the influence of various factors like percentage of patients with alcoholic liver disease (ald) as cause of cirrhosis, dose of terlipressin used (>4mg/d and<4mg/d); type of interventions used (terlipressin with vs without albumin; terlipressin vs placebo; terlipressin vs noradrenaline), blinding and quality score of study (studies of low quality vs high quality) was also conducted. |
| PubMedID- 23247798 | Background: primary sclerosing cholangitis (psc) is a chronic cholestatic liver disease leading to cirrhosis and cholangiocellular carcinoma. |
| PubMedID- 24030843 | Liver cirrhosis is the end-stage of long-standing chronic liver diseases. |
| PubMedID- 22893871 | Data at enrollment, including age, sex, ctp score, model for end-stage liver disease (meld) score, cause of cirrhosis, presence of esophageal varix, use of antiviral treatment, coexistence of diabetes, coexistence of hypertension, prothrombin time, international normalized ratio, albumin, total bilirubin, creatinine, aspartate aminotransferase, and alanine aminotransferase, were collected. |
| PubMedID- 23339829 | cirrhosis is a consequence of chronic liver disease commonly caused by alcoholism, viral hepatitis, autoimmune disorders, or other aetiologies. |
| PubMedID- 22648736 | cirrhosis is a form of end-stage liver disease that is the culmination of a number of chronic liver disorders. |
| PubMedID- 24129500 | Purposes: hepatic lipid overloading induces lipotoxicity which can cause hepatocyte damage, fibrosis, and eventually progress to cirrhosis, which is associated with nonalcoholic fatty liver disease. |
| PubMedID- 24714782 | Since cirrhosis represents the end-stage of any chronic liver disease, it has been mandatory to elaborate reliable and accurate predictors of its severity and prognosis. |
| PubMedID- 23178709 | Background & aims: autoimmune hepatitis is a chronic inflammatory liver disease that leads to liver cirrhosis and corresponding complications, if left untreated. |
| PubMedID- 21372348 | Exclusion criteria were previous history of ear disease, active auditory symptoms at the time of recruitment, decompensated cirrhosis, other causes of liver disease, autoimmune disorders and other severe comorbidities such as neoplastic, cardiac, hematologic and psychiatric diseases. |
| PubMedID- 24106597 | Liver fibrosis and its end-stage disease, cirrhosis, are outcomes of many chronic liver diseases, such as viral hepatitis and of alcohol consumption and drug abuse (27). |
| PubMedID- 23805158 | Concurrently, persistent chronic hcv infection more potent to developed cirrhosis, end stage of liver disease, and hepatocellular carcinoma is a result of hepatocellular necrosis among other hepatitis virus types (4, 10). |
| PubMedID- 21829583 | cirrhosis represents the end-stage of any chronic liver disease, characterized by the most advanced stage of fibrosis, distortion of the liver parenchyma associated with septae and nodule formation, altered blood flow and the potential development of liver failure at long term. |
| PubMedID- 24714308 | In another study, anti-p were found in 40% of patients with primary biliary cirrhosis, but not in patients with alcoholic liver disease . |
| PubMedID- 23303023 | cirrhosis, end-stage of many liver diseases, presents many complications during its evolution. |
| PubMedID- 26556483 | Through subgroup meta-analysis, we identified significant hepatoprotective effects of coffee consumption on hepatic fibrosis and cirrhosis in patients with alcoholic liver disease and chronic hcv infection, which mainly contribute to cld in western countries. |
| PubMedID- 23886860 | Mice fed a diet containing 40% fat (of which approximately 18% was trans fat), 22% fructose, and 2% cholesterol developed three stages of nonalcoholic fatty liver disease (steatosis, steatohepatitis with fibrosis, and cirrhosis) as assessed by histological and biochemical methods. |
| PubMedID- 21994876 | Lamivudine, the first oral antiviral agent available for hepatitis b treatment is safe and effective and can improve or stabilize liver disease in patients with advanced cirrhosis and viraemia. |
| PubMedID- 25298585 | this includes age, type of hrs, alcoholic liver disease (ald) as cause of cirrhosis, baseline map level, baseline serum bilirubin level, baseline serum creatinine level, baseline child-pugh score and others. |
| PubMedID- 25191479 | Significant reductions in serum and tissue aat levels in human beings are associated with chronic obstructive pulmonary disease (copd) especially pulmonary emphysema and liver disease which can lead to cirrhosis, necrotizing panniculitis and vasculitis (3, 4). |
| PubMedID- 21633726 | Transient elastography is a noninvasive method for detection of cirrhosis in patients with chronic liver disease by measuring the liver stiffness. |
| PubMedID- 22967278 | Liver cirrhosis, the end-stage of various liver diseases, has a poor prognosis, which is determined by deterioration of hepatic functional capacity and consecutive development of hepatic complications. |
| PubMedID- 24093051 | Pre-operative liver function tests should be performed in those with established cirrhosis or a history of liver disease, or excessive alcohol intake . |
| PubMedID- 23577631 | About 20-30% of patients could develop a progressive liver disease leading to cirrhosis and hcc . |
| PubMedID- 26386160 | As this cohort ages, progressive hcv-related liver disease leading to cirrhosis and hepatocellular carcinoma (hcc) will place a significant burden on the healthcare system. |
| PubMedID- 22102439 | Although other outcomes related to non-alcoholic fatty liver disease, including cirrhosis, cancer, and a more rapid progression of coexistent liver diseases may be important, our findings support the suggestion that people with accumulation of fat in the liver have a good prognosis with respect to mortality. |
| PubMedID- 24905107 | Background: chronic liver disease leads to fibrosis and cirrhosis of the liver. |
| PubMedID- 20496758 | Conclusions: real-time tissue elastography is a useful method for the diagnosis of significant fibrosis and cirrhosis in patients with chronic liver diseases. |
| PubMedID- 26034765 | Hepatic steatosis is the first pathophysiological step for nonalcoholic steatohepatitis (nash), a progressive liver disease leading to cirrhosis and related complications 6. |
| PubMedID- 26473801 | Conclusions: hyperhomocysteinemia is frequently present in patients with cirrhosis and is associated with severe liver disease and reduced graft and patient survival after liver transplantation. |
| PubMedID- 22576780 | Background: non-alcoholic fatty liver disease (nafld) can lead to cirrhosis and hepatocellular carcinoma and is strongly associated with obesity and insulin resistance. |
| PubMedID- 24796378 | Aim: liver fibrosis occurs as a result of several chronic liver diseases and leads to portal hypertension, cirrhosis and liver failure, often requiring liver transplantation. |
| PubMedID- 24763757 | The relationship between symptomatic high risk for osas and liver damage seemed also independent of advanced liver disease, as patients with decompensated cirrhosis were excluded from the study, and the association between high risk for osas with sleepiness and steatosis grade and fibrosis stage >1 was maintained even after exclusion of patients with compensated cirrhosis. |
| PubMedID- 21884247 | Entecavir treatment for 12 months decreased mean model for end-stage liver disease scores in patients with cirrhosis and hcc (7.2 vs 5.6, p < 0.001). |
| PubMedID- 20619382 | Background: hepatitis c virus (hcv) causes chronic liver disease that often leads to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 25175670 | Case presentation: a 76-year-old caucasian man with liver cirrhosis due to non-alcoholic fatty liver disease, and type-2 diabetes was cognitively impaired and had reduced vigilance presumably caused by hepatic encephalopathy and/or alzheimer dementia. |
| PubMedID- 22052005 | Recent studies have shown that the pathogenetic pathways of chronic fibrotic liver disease leading to cirrhosis are identical in man and dog (ijzer et al. |
| PubMedID- 24455970 | This study included 313 normoalbuminuric type 1 diabetic patients with estimated glomerular filtration rate (egfr) >60 ml/min/1.73 m(2), without clinical evidence of cirrhosis or other causes of chronic liver disease and before any interventions with statins, angiotensin-converting enzyme (ace) inhibitors or angiotensin ii receptor blockers. |
| PubMedID- 23091807 | Patients with liver cirrhosis and other forms of liver disease or other severe underlying diseases, i.e. |
| PubMedID- 21957486 | Nafld-related cirrhosis can lead to end-stage liver disease and hepatocellular carcinoma (hcc). |
| PubMedID- 22760651 | The addition of hdv to an hiv/hbv coinfection is associated with a particularly aggressive course of liver disease, frequently leading to cirrhosis, decompensation, and death. |
| PubMedID- 26494212 | As hcc is closely related to liver cirrhosis, the monitoring of chronic liver diseases is of considerable importance. |
| PubMedID- 22567408 | Until recently, transplantation was considered the only viable treatment option for cirrhosis and severe forms of liver disease . |
| PubMedID- 25263751 | Patients with compensated liver disease, including cirrhosis, were eligible for inclusion in this study. |
| PubMedID- 24392025 | cirrhosis, the final stage of chronic diffuse liver disease, is histologically defined as the presence of regenerative nodules surrounded by fibrous bands in response to chronic liver injury, resulting in the distortion of the hepatic vasculature and consecutive portal hypertension 1. |
| PubMedID- 26362514 | The diagnosis requires the exclusion of cirrhosis, common causes of chronic liver disease and venous obstruction of the portal and hepatic veins. |
| PubMedID- 24843689 | In a 21‐year follow up of biopsy‐proven nafld, the main causes of death were cardiovascular disease and malignancy12, as opposed to cirrhosis in those with alcoholic liver disease. |
| PubMedID- 24281095 | Hepatitis b and c viral infection is the most common underlying cause of chronic liver disease leading to liver cirrhosis, and aflatoxin b1 and alcohol are also well-known risk factors. |
| PubMedID- 23374914 | Around the world, infection by the hepatitis c virus (hcv) causes acute and chronic liver disease and may lead to cirrhosis, liver failure and/or hepatocellular carcinoma. |